NASDAQ$CERT
Certara Inc. · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
Certara Inc. reported financial results for the second quarter ended June 30, 2025.
Certara reported total revenues of $104.6 million for Q2 2025, up 12% year-over-year, with software revenue growing 22% to $46.7 million and services revenue increasing 5% to $57.9 million. The company recorded a net loss of $2.0 million and income from operations of $9.6 million. Strong demand for biosimulation software and technology-enabled services drove growth, supported by the Chemaxon acquisition.
- Total revenues reached $104.6 million, reflecting 12% growth driven by software and services demand.
- Software revenues increased 22% to $46.7 million, while services grew 5% to $57.9 million.
- Net loss narrowed to $2.0 million from $12.6 million in the prior-year quarter.
- Adjusted EBITDA rose to $31.9 million, demonstrating improved operational efficiency.
Headline financials
Revenue & EPS history
Certara · Revenue · Quarterly
$105M
Revenue by segment
Certara · $105M total across 2 segments · Q2 2025
- Services$57.9M—55.3%
- Software$46.7M—44.7%
Forward guidance
The company continues to invest in biosimulation and AI capabilities while monitoring regulatory and macroeconomic conditions.
Tailwinds
- Strong customer retention with net retention rates above 100%.
- Expansion of software bookings and adoption of MIDD strategies.
Headwinds
- Potential impacts from regulatory changes and industry consolidation.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports
-4.5%
Avg return
Earnings day
-6.4%
Avg return
5 days after
-3.8%
Avg return
30 days after
33%
8 / 24 earnings
Positive
+28.1%
Q3 2022
Best reaction
-23.0%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -18.9% | -29.2% | -17.9% | |
| Q4 2025 | +3.3% | +9.9% | -12.7% | |
| Q3 2025 | -23.0% | -26.5% | -18.2% | |
| Q1 2025 | -11.0% | -6.3% | -8.5% | |
| Q3 2024 | +6.6% | +5.6% | +5.2% | |
| Q2 2024 | -12.6% | -16.1% | -23.1% | |
| Q1 2024 | -7.3% | -3.6% | -2.6% | |
| Q4 2023 | +7.8% | +9.6% | +5.3% | |
| Q3 2023 | +0.6% | +3.5% | +30.6% | |
| Q2 2023 | -10.0% | -6.5% | -19.5% | |
| Q1 2023 | -9.5% | -12.1% | -18.9% | |
| Q4 2022 | +19.4% | +18.4% | +33.1% | |
| Q3 2022 | +28.1% | +37.6% | +64.0% | |
| Q2 2022 | -15.6% | -27.2% | -32.6% | |
| Q1 2022 | -2.5% | -11.3% | -1.4% | |
| Q4 2021 | -13.5% | -21.9% | -15.2% | |
| Q4 2019 | -13.5% | -21.9% | -15.2% | |
| Q3 2021 | -5.5% | -7.4% | -33.7% | |
| Q3 2020 | -5.5% | -7.4% | -33.7% | |
| Q2 2020 | +0.6% | +0.3% | +34.9% | |
| Q2 2021 | +2.3% | -0.0% | +35.3% | |
| Q1 2020 | -0.1% | -7.9% | -10.7% | |
| Q1 2021 | -6.1% | -9.9% | -16.4% | |
| Q4 2020 | -22.2% | -23.5% | -19.1% | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro